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The significance of indirect costs in the cost price calculation of
clinical chemistry laboratory tests.by way of the production centres
method has been investigated. A cost structure model based on the
’production centres’ method, the Academisch Ziekenhuis Groningen
(AZG) 1-2-3 model, is usedfor the calculation of cost and cost
prices as an add-in tool to the spreadsheet program Lotus 1-2-3.
The system specifications of the AZG 1-2-3 cost structure model
have been extended with facilities to impute all relevant indirect
costs to cost centres by aid ofallocation rules, which can be chosen
freely. The inference is made that as indirect costs play a more
important part in decision-making processes concerning planning
and control, the specification of the relation to the cost centres
should be determined in a more detailed way. TheAZG 1-2-3 cost
structure model has therefore been extended in order to increase the
significance as a management toolfor laboratory.management.
Introduction
The registration ofcosts and the calculation ofcost prices
in health care, especially for laboratory tests, are increas-
ingly important [1-3]. Among other things, interest is
focused on computer systems with which all relevant
costs, both direct and indirect, can be registered. By
means ofdatabases, the costs ofthe activities oforganiza-
tional units can be determined beforehand and the cost
prices of services to be rendered and the consequences of
policy decisions can be judged.
Recently, the Academisch Ziekenhuis Groningen (AZG)
1-2-3 cost structure model has been developed by us as a
support for the decision-making concerning the allocation
of production factors [4]. In principle, direct costs in
addition to indirect costs can be fed into the model. This
takes place through an addition method with which the
indirect costs are transformed into direct costs. In
everyday practice it often appears to be a problem to
determine the relation between indirect and direct costs
unambiguously.
In this paper, the significance of indirect costs in the
overall costs of clinical chemistry tests is examined. Here
the question is raised of the way in which the AZG 1-2-3
cost structure model should possibly be adjusted in order
to allocate the relevant indirect costs according to the
activities, taking into account the nature of the various
indirect costs.
Costs in an organization
In any organization costs are incurred. Costs are defined
as an aggregate ofapplied quantities ofproduction factors
multiplied by their prices per unit. Usually costs are
subdivided into categories. Thus direct and indirect costs
are distinguished in addition to fixed and variable costs.
The distinction between direct and indirect costs is very
significant for an organization, as thereby a specification
is given ofthe coherence between products, functions and
activities existing in any organization. This is a specifica-
tion that is especially significant for management making
decisions on matters of planning and control.
Direct costs are costs that can be directly related to a
particular product on the basis of a technical and
organizational relationship. Indirect costs do not have
this characteristic and usually they can be imputed
directly to functions and activities only. They can be
imputed (in commercial economics the term used is
’allocated’) to products on the basis of allocations which
are often arbitrary. The distinction between direct and
indirect is first of all dependent on the definition of the
term product. Strictly, in cost-price calculation a product
is defined as the final products (services) which are
marketed by an organization and for which a price is paid
and/or for which a remuneration is obtained (e.g. from a
giver of grants). In order to effect a good balance of the
exchange process possible, the price will have to be
compared with the cost-price of the final product. It is
obvious that the indirect costs will have been included in
the cost-price in one way or another.
In a hospital organization, the diagnoses and therapies
are the final products, which are compensated by returns
in the form of rates for days of treatment, consultations
and operations. The costs which show a direct relation to
these final products are direct in nature and those which
do not show this characteristic are indirect. Strictly, this
means that all costs of departments such as the labora-
tory, technical department and civil department, are
considered to be indirect by the organization of the
hospital. This is one of the reasons why the costs and
achievements of the laboratory are registered in one
auxiliary cost centre in hospital administration.
* To whom correspondence should be addressed.
From the point of view of planning and control, the
various services and departments of larger organizations
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are split into sub-systems, so that each sub-system can be
studied separately. The products ofmost sub-systems are
then regarded as achievements (intermediate products),
for which there is no direct relation to the return of the
organization. In fact, the products of most sub-systems
are achievements which contribute to the realization of
the quality of the final products of the organization. In
order to judge the control of a department or service in
hospital organization, it is necessary that beforehand
statements can be made on the cost and return to be
expected (planning) and that afterwards it can be
checked whether the control was either good or bad.
Therefore, figures on the total cost and return per
department or service beforehand and afterwards are
necessary. The mutual supplies of achievements among
the sub-systems of an organization should therefore be
registered by means of internal imputation systems. The
way in which this takes place, particularly the extent of
specification, determines the way in which control can be
judged.
Allocation of costs
By means of the costs a cost-price per product, service or
achievement can be calculated. By cost-price, the amount
of direct and indirect costs per product unit is meant.
There are various methods for the cost-price calculation
of final products. Two examples, of which the second is
suitable for planning, are the following.
Primitive addition method. The indirect costs are imputed to
the separate products in the form of an addition to (part
of) the direct costs.
Production centres method. According to this method, the
various costs are imputed to the various products on the
basis of the relation of the application of production
factors which caused the costs for the realization of the
products. It should be investigated how far achievements,
coming from different organizational sub-systems, were
necessary for each product and therefore have to be
considered as an indispendable ’derived’ production
factor. With this information, allocations can be deter-
mined.
The allocation of costs through the production centres
method assumes an organization in which various
functions with the costs connected to them are dis-
tinguished, which can be imputed to other functions or
products. These functions are called cost centres and the
final products are called cost bearers.
Auxiliary cost centres are cost centres that supply
achievements, not final products. The costs of auxiliary
cost centres are imputed to other auxiliary or main cost
centres.
Main cost centres are the cost centres of which the
achievements directly benefit the final products, the cost
bearers. The production centres method, which forms the
basis for the AZG 1-2-3 cost structure model, is the
method of cost price calculation in which the coherence
Table 1. Supplies ofservices to and within our laboratory entailing
indirect costs and stating the share in the total cost of laboratory
tests.
Share (%)
1. Sample collection
2. Sample transportation
3. Preparation ofwork and distribution
4. General services
5. Service and maintenance
6. Computer system
7. Management and supervision
8. Administration
9. Training, education and research
10. Housing
11. Scientific staff
12. Laundry
Total share ofindirect costs
5
<1
3
3
6
5
4
2
6
5
2
<l
40
Note: one part ofthe indirect costs has not been included in this
set-up, i.e. hospital management, and another part, housing
and scientific staff, is probably too low in this estimation.
between the achievements and final products are expli-
citly laid down. This coherence in a way represents the
production structure of an organization and it is essen-
tially important in judging the control.
Indirect costs
Many mutual supplies of both external and internal
achievements to which indirect costs are entailed can be
distinguished in the clinical chemistry laboratory. An
inventory ofservices and the indirect costs entailed in our
laboratory are stated in table 1.
The question to be asked now is which indirect costs are
relevant to be involved in the cost price calculation. For
this purpose the relation to the products, the results of
laboratory analysis should be determined. Cost-price
calculation is applied in organizations to support the
many decisions that are made, where costs and cost-
prices are used as a criterion.
The need to consider indirect costs in cost price calcula-
tion is based on a number of reasons"
1. From the planning point of view, it is necessary to
judge alternative application possibilities of production
factors through which changes in the conduct ofbusiness
and organization of the mutual supplies result. In the
clinical laboratory the sample collection, transportation,
reception and preparation of work come into considera-
tion here. However, the organization of the warehouse,
the cleaning room and the administration are also
important.
2. Costs are used to make statements on the efficiency of
an organization and as a means to control efficiency, e.g.
by budgetting. By efficiency is meant the extent to which
an organization is capable to achieve a certain goal with
175F. R. Hindriks et al. Indirect costs in clinical laboratory tests
the given means, this goal often being a certain rate of
production. In order to make statements on this, the cost
function will have to be divided into the production
functions lying behind it. As achievements to which
indirect costs are entailed contribute considerably to the
realization and quality of the products, it is important to
include the indirect costs in the calculation of cost,
especially in order to be able to determine if the supply
meets the desired specifications of efficiency and quality,
and if the compensation obtained for it is sufficient.
3. In the development ot tianctional budgetting, the
significance of know-how concerning the cost of labora-
tory tests is increasing because alternative application
possibilities of the clinical laboratory can favourably
affect the allocation of the budgetted production factors
within the hospital organisation. In the near future the
clinical laboratories will be faced more emphatically with
the question of utilization of analytical equipment and
staff. Considerations of the capacity to be put into service
are affected by the possibilities of having activities
executed by external laboratories or by attracting
research from outside the organization in order to realize
a more favourable rate of utilization. For both situations
it is important to know all relevant costs for laboratory
tests.
For ajudgement by the management, these three reasons
have to be stated with the relevant arguments, which is
why indirect costs cannot be excluded from considera-
tion.
Usually it is difficult to transform indirect costs into direct
costs, as a direct relation with the results of analysis
cannot be derived. The indirect costs specified in table
comprise a considerable part of the total costs of our
laboratory (at least 40%). With this the ratio of direct
and indirect costs is 3:2.
The AZG 1-2-3 cost structure model and indirect
costs
In the original version of the AZG 1-2-3 cost structure
model, indirect costs, in as far as this is relevant and
realizable, can be transformed into direct costs or be
imputed to the main cost centres by way ofa variant ofthe
primitive addition method. This method is based on the
assumption that the ratio of indirect costs (overhead) to
the total cost is equal for every sort of activity, and
corresponds to the ratio oftotal indirect costs to total cost.
In everyday practice, it can be questioned whether this
assumption is correct. Should this not be the case, the rule
used in the primitive addition method has to be specified
further. Such rules are called allocstion rules.
An allocation rule consists of quantities or factors by
means of which indirect costs can be split up. They are
rules that specit/the relations between the achievements
which were made and the production of final products or
achievements. The factors included in these rules will
differ according to the nature of the existing relations and
the desired accuracy with which they are described.
These factors are expressed in physical units of the
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achievement to be made (e.g. the number of kilowatt
hours in electricity). Some examples of these factors are
the number of tests, direct costs per activity, surface
measure and number of employees.
Per auxiliary cost centre, one or more allocation rules are
specified by which the costs can be allocated. Then an
allocation will result.
The indirect costs are imputed by way of the following
equation:
k Kj.[xo/Y(x Xim)]
where kij the indirect costs of the auxiliary cost centre
which is imputed to the productj; iij 1... m; Kji the
total cost of the achievement i; and Xim the technical
factor of achievement for the specified products from
up to and including m series.
The distribution of indirect costs into the various
activities by means ofallocations have thus been included
in the AZG 1-2-3 cost structure model.
TheAZG 1-2-3 application program, based on the Lotus
1-2-3 program, has been extended with facilities to
distribute indirect costs over various activities by alloca-
tions known or to be chosen. The program can be applied
on any IBM-compatible microcomputer with an internal
memory of at least 384 kB, DOS operating system and
using the Lotus 1-2-3 program.
Examples of application
To illustrate the allocation of indirect costs, the cost of
housing and computer usage will serve as examples.
Housing
As a rule it is generally accepted that the cost ofhousing is
allocated by the ratio ofthe number ofnet square metres.
The price per square metre is determined by
Pji Kji/total number of square metres
where Pji the cost-price of achievement (in this case
housing).
For the calculation of the contribution ofindirect costs of
housing to a certain achievement j, the number of net
square metres that has to be hired for the production ofj
should be determined. A relation between the production
ofj and the number ofachievements of/in the case ofcost
of housing usually does not exist. In order to produce the
achievement, j square metres are needed. This number
will not flucutuate with the real production ofj. Mostly an
amount is calculated that consists ofpji times the number
of square metres needed.
Computer costs
An example showing detailed figures of the imputation of
indirect costs of computer usage to the achievements of
the SMAC automated analyser (Technicon Instruments,F. R. Hindriks et al. Indirect costs in clinical laboratory tests
Table 2. Source data with relation to the achievements of the hospital computer.
Hospital computer achievements
CKCL* share
Total (%)
Costs according to
system oftariffs]"
CPU time 468 037 437 15"2
Disc
accesses 568 052 673 17.9
SPOOL
records 163 760612 19"
Total
x Dfl l’E-4 Dfl 78 256
X Dfl 35.E-4 Dfl 928 385
x Dfl 30.E-4 Dfl 93 835
Dfl 154 476
* Abbreviation of our laboratory.
"
Dfl Dutch guilders.
Table 3. Source data with relation the achievements ofthe SMAC
analyser.
CKCL achievements
Total SMAC share (%)
Tests 2 895 314 55"3
Requests 425681 31"3
Direct costs (Dfl) 8 285 600 11-3
Table 4. Results of imputing costs of hospital computer to the
SMAC analyser in three different ways (all amounts in guilders).
Production centres method
Addition Allocation Technical
method rule coefficient
Per request 0-98 2"71 2"93
Per test 0"08 0"40 0"24
Imputation 130 456 361 350 390 944
Tarrytown, NY, USA) illustrates the significance of the
imputation of indirect costs in case there exists a direct
relation between the production ofj and the number of
achievements of i.
It can easily be seen that there is a relation between the
SMAC production (number of tests or requests) and the
application of the hospital computer (in the form ofCPU
time, disc accesses, SPOOL records) as a production
factor. It is relatively easy (though time consuming) to
determine the amount taken up by SMAC through the
account data of the computer system (see table 2). It will
be more difficult to define the achievement unit of the
computer system, the system second, and to calculate a
price per unit for it, as the specifications lying behind it
are very arbitrary.
In practice, computer costs are often allocated through a
tariff system, for which it is not clear in what way it was
specified, as a result of which gross inaccuracies can
result. As the decisions that are made partly on the basis
of the results of allocation of costs are considered more
important, the imputation of costs should take place in a
more detailed (and hence more accurate) way. In such a
case an application of the indirect costs on the basis of a
simple addition method will not suffice; instead, taking
into consideration the relation with the production ofj,
the application of the computer will have to be deter-
mined as a technical coefficient, and the costs entailed to
be considered direct.
In tables 2 and 3, the source data with respect of the
achievements of the hospital computer and the SMAC
analyser in our laboratory are stated. In various ways the
indirect costs for the use of the hospital computer can be
imputed, the results of which are stated in table 4. The
calculations are given in the Appendix. Note that 1
corresponds with about Dfl 3.70.
The results show that large differences in the imputation
arise and that it is essential to recognize them as such and
to realize that these differences are strongly dependent on
the chosen (arbitrary) rules lying behind it. In practice, it
is often chosen as a starting point to impute indirect costs
on a high aggregation level as the difficult specification is
not always necessary. As the decisions based on that are
considered more important, the necessity of specifying
the relations concerned in more detail will increase.
The primitive addition method takes these computer
costs as fixed and distributes these costs to the laboratory
products (requests, tests) randomly, not based on any
specification of the relation between computer achieve-
ments and laboratory products. The method can impute
these costs after they have been made.
The production centres method imputes costs according
to the specification of the relation between the computer
achievements and the laboratory production process,
which gives results closer to reality than the primitive
addition method.
The imputation through technical coefficients is time
consuming because of the detailed specification of the
workload, i.e. the definition of the unit of computer
achievement, the system second and the relation between
the system second and the laboratory products. A great
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advantage for reasons of planning and control, is to use
this method beforehand. This method can be considered
as a reference method.
The use ofallocation rules is simple and quick to perform.
It seems to be the second-best method and for many
applications gives relevant information sufficient to make
the right decisions.
List of definitions
Activity: A description of a technical transformation
process that for certain reasons can be considered as a
unit and that results in the production offinal products or
intermediate products.
Allocation: Allocation of the indirect costs which an
auxiliary cost centre imputes to a number of main cost
centres.
Allocation rule: An allocation rule consists of quantities or
factors by means of which the indirect costs of an
auxiliary cost centre can be allocated to specified
activities.
Cost: Aggregate of production factors used multiplied by
their prices per unit to produce a certain production
quantity.
Cost centre: An organization unit, in which all costs, with
reference to certain activities, are specified. See also
Activity.
Direct and indirect costs: Direct costs are costs that can be
related directly to a particular final product on the basis
of a technical and organizational relation. Indirect costs
do not have this characteristic, but they can usually be
directly imputed to functions and activities on the basis of
causal relations.
Finalproduct: The output ofan activity which is sold by the
organization and to which the revenues are directly
related.
Intermediate product (achievement): Intermediates or inter-
mediate products are the output of these activities that
are not sold by the organization but which are necessary
to produce the final products.
Occupancy: Indicates which portion of the availability
capacity of production factors is utilized.
Production factor: Is applied for the sake of activities in
realizing (final) products.
Production quantity: Number of units of an activity pro-
duced in a certain time period.
Rate ofapplication: The use ofa production factor per unit
time in order to achieve a certain rate of production.
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Appendix
Imputing the costs ofthe hospital computer to the SMAC
analyser in three different ways:
1. The primitive addition method
The share ofSMAC in the total CKCL costs is 11"3%; in
total Dfl 154476 is imputed to the laboratory. The
addition for SMAC is then 11"3% ofDfl 154476 or in
total Dfl 130 456, i.e. Dfl 0"98 per request or Dfl 0"08 per
test.
2. Allocation through allocation rules (production centres method)
The indirect costs ofcomputer usage are allocated by the
ratio of the number of tests or in a given case the number
of requests into the activities of SMAC. The share of
SMAC in the total number ofCKCL tests or requests is
55"3% and 31-3%, respectively. Imputation to SMAC
through 55"3% ofDfl 154476 over 601 136 tests will
then result in an addition of Dfl 0"40 per test or through
31"3% ofDfl 154476 over 133428 requests in Dfl 2"71
per request.
3. Through technical coefficients roduction centres method)
There is a relation between the production of the SMAC
activity and the achievements of the hospital information
system, which can be indicated by the determination ofa
technical coefficient.
The hospital computer production factor is expressed in
the physical unit of the system second (syssec) and has
been defined as follows:
unit 0"222 CPU time + 0-688 disc access +
0"09 SPOOL record
The price per unit of the syssec amounts to Dfl 29.E-4
according to the system of tariffs.
The technical coefficient of the hospital computer pro-
duction factor for SMAC activity amounts to 1005 syssec,
i.e. dealing with (producing) one request by SMAC takes
up 1005 syssec of the hospital information system.
Because of the relation between production and supplied
achievement, the costs of hospital computer usage are
considered direct by the SMAC analyser. The eventual
addition will result in Dfl 2"93 per request or Dfl 0"24 per
test.
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